Roche Diagnostics, Sydney, New South Wales, Australia.
Clin Chem Lab Med. 2013 May;51(5):943-52. doi: 10.1515/cclm-2013-0011.
Glucose meters have improved considerably since they were first introduced in 1960, but many questions are being asked about their accuracy and reliability in certain clinical situations. These questions have arisen because of the widespread use of these meters into clinical areas they have not been designed for such as critical care. The lack of understanding by some health professionals on factors that affect glucose results, such as sample type, glucose test strip methodologic limitations, calibration to recognized reference methods, and interferences, leads to misleading results that may affect patient care. Much debate continues on the quality specifications for glucose meters. Because there is an extensive use of these meters in different clinical scenarios, the setting of quality specifications will remain a challenge for regulatory and professional organizations. In this article, we have attempted to collect and provide relevant information addressing the limitations above. Pivotal to obtaining the best quality of results is education, particularly for diabetic patients monitoring their glucose. The International Federation of Clinical Chemistry and Laboratory Medicine through its Point-of-Care Testing Task Force and its Working Group on Glucose Point-of-Care Testing is actively working toward improving the quality of glucose results by improving education and working with the industry to improve strip performance and work toward the better standardization of strips.
血糖仪自 1960 年问世以来已经有了很大的改进，但在某些临床情况下，人们对其准确性和可靠性提出了许多质疑。这些质疑的出现是由于这些血糖仪在设计范围之外的临床领域得到了广泛应用，如重症监护。一些卫生专业人员对影响血糖结果的因素缺乏了解，例如样本类型、血糖测试条方法学限制、与公认参考方法的校准以及干扰，这导致了可能影响患者治疗的误导性结果。关于血糖仪的质量规格仍存在许多争议。由于这些血糖仪在不同的临床场景中得到了广泛应用，因此为监管和专业组织设定质量规格仍然是一项挑战。在本文中，我们试图收集并提供有关上述限制的相关信息。获得最佳结果质量的关键是教育，特别是对于监测血糖的糖尿病患者。国际临床化学和实验室医学联合会通过其即时检验工作组及其即时血糖检测工作组，正在积极努力通过提高教育质量来改善血糖检测结果，并与行业合作，改善测试条性能，努力实现更好的测试条标准化。
